LabGenius amasses over $10 mln Series A

LabGenius, a UK-based provider of an AI-driven drug discovery platform, has raised over $10 million in Series A financing. Lux Capital and Obvious Ventures led the round with participation from other investors that included Felicis Ventures, Inovia Capital, Gigafund and Air Street Capital.

CanadaNorth AmericaUSBriefs